OnKure Therapeutics, Inc (OKUR) insider trading
Every open-market stock purchase and sale by OnKure Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Jason A. Leverone (CFO) and 1 other sold $1.2K in the last 90 days.
- Last insider buy: Acorn Bioventures L.p. (Insider), $2.1M, 17 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $5.6K (8 sales). Last close $2.90 on Sep 25, 2026.
Recent OKUR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 21, 2026 | Jason A. Leverone (CFO) | Sold | $898 |
| Sep 21, 2026 | Nicholas A Saccomano (CEO) | Sold | $259 |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Sold (not open market) | $9.9M |
| Aug 7, 2026 | Dylan Hartley (C-suite exec) | Sold (not open market) | $2.5M |
| Aug 7, 2026 | Samuel Agresta (C-suite exec) | Sold (not open market) | $2.4M |
| Aug 7, 2026 | Jason A. Leverone (CFO) | Sold (not open market) | $2.4M |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Bought (not open market) | $2.2M |
| Aug 7, 2026 | Dylan Hartley (C-suite exec) | Bought (not open market) | $570K |
| Aug 7, 2026 | Samuel Agresta (C-suite exec) | Bought (not open market) | $544K |
| Aug 7, 2026 | Jason A. Leverone (CFO) | Bought (not open market) | $541K |
| Aug 7, 2026 | Isaac Manke (Insider) | Sold (not open market) | $278K |
| Aug 7, 2026 | Samuel Agresta (C-suite exec) | Sold (not open market) | $260K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Sold (not open market) | $236K |
| Aug 7, 2026 | Jason A. Leverone (CFO) | Sold (not open market) | $123K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Sold (not open market) | $118K |
| Aug 7, 2026 | Samuel Agresta (C-suite exec) | Bought (not open market) | $77K |
| Aug 7, 2026 | Jason A. Leverone (CFO) | Sold (not open market) | $74.5K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Bought (not open market) | $70K |
| Aug 7, 2026 | Isaac Manke (Insider) | Bought (not open market) | $63.3K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Sold (not open market) | $50K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Bought (not open market) | $35K |
| Aug 7, 2026 | Jason A. Leverone (CFO) | Bought (not open market) | $23.9K |
| Aug 7, 2026 | Jason A. Leverone (CFO) | Bought (not open market) | $22K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Sold (not open market) | $20.8K |
| Aug 7, 2026 | Nicholas A Saccomano (CEO) | Bought (not open market) | $9.8K |
Who's trading OKUR
- Jason A. Leverone, CFO: sold $4.4K (4 sales), last Sep 21, 2026
- Nicholas A Saccomano, CEO: sold $1.3K (4 sales), last Sep 21, 2026
- R Michael Carruthers, Insider: other filings, last Aug 7, 2026
- Samuel Agresta, C-suite exec: other filings, last Aug 7, 2026
- Michael G Grey, Insider: other filings, last Aug 7, 2026
- Dylan Hartley, C-suite exec: other filings, last Aug 7, 2026
- Valerie Malyvanh Jansen, Insider: other filings, last Aug 7, 2026
- Isaac Manke, Insider: other filings, last Aug 7, 2026
- Andrew John Phillips, Insider: other filings, last Aug 7, 2026
- Liam Ratcliffe, Insider: other filings, last Aug 7, 2026
- Edward T Mathers, Insider: other filings, last Jun 4, 2026
Get free alerts when an insider at OnKure Therapeutics, Inc files a new trade →